UCB Celltech - Company Review
UCB Celltech - Company ReviewSummary
UCB Celltech (UCB), formerly Celltech Group PLC, a subsidiary of UCB SA is a healthcare services provider that conducts research and development of therapies. The company’s products include certolizumab pegol, nifedipine, glyceryl trinitrate, docusate sodium, olsalazine sodium, isosorbide mononitrate, ethinyloestradiol, isosorbide dinitrate, isosorbide dinitrate, levetiracetam, and others. It provides amiodarone hydrochloride, atropine sulphate, calcium chloride dihydrate, adrenaline, furosemide, glucose, lidocaine, magnesium sulphate, morphine sulphate, naloxone, sodium bicarbonate and others. UCB also offers rotigotine, glyceryl trinitrate, piracetam, moexipril hydrochloride, codeine phosphate hemihydrate, hydroxyzine hydrochloride, lacosamide, alprostadil, oxybate sodium, and levocetirizine dihydrochloride. The company provides its products to different parts of Europe. UCB is headquartered in Slough, the UK.
This comprehensive company report of UCB Celltech provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.